Indian Army Tender Hyderabad Semaglutide and Antiviral/Hydroxyurea Medicines Procurement 2026

Tender Overview

The Indian Army, Department Of Military Affairs, headquartered in Hyderabad, Telangana, invites bids for the supply of a medicines bundle consisting of Inj Semaglutide (0.25 mg, 0.50 mg, 1 mg, 4 mg) and tablets Letermovir 240 mg plus Hydroxyurea 500 mg. The bundle comprises 6 total items under a supply-only scope, with Bid price to include all costs. The tender accommodates quantity fluctuations up to 25% at contract, and delivery timing aligns to the last delivery order date, with minimum additional time of 30 days. This procurement emphasizes reliable, compliant pharmaceutical supply to meet clinical needs in a defense context.

Technical Specifications & Requirements

• Product names: Inj Semaglutide 0.25 mg, 0.50 mg, 1 mg, 4 mg; Tab Letermovir 240 mg; Tab Hydroxyurea 500 mg
• Category: injectable anti-diabetic/glucose-lowering agent and antiviral + anticancer agent tablets
• Quantity/scale: 6 items listed; exact quantities not disclosed
• Delivery scope: Only supply of Goods; all costs included in bid price
• Special terms: Quantity may increase by up to 25% during contract; delivery period begins from the last date of original delivery order; extended period logic includes a minimum of 30 days; option to extend delivery within contracted rates
• Compliance expectations: product must be safely storable and transportable to military facilities in Hyderabad, terms imply standard pharmaceutical warehousing compatibility
• BOQ: 6 items, with all item quantities listed as N/A; bidders should prepare for flexible inventory planning

Terms, Conditions & Eligibility

• EMD: not specified in the provided data
• Payment terms: not specified; bid to include all costs
• Delivery: delivery period triggers from original order date with 30-day minimum extension when exercising option clause
• Scope: only supply of goods; no installation or services
• Documentation: bidders must align with generic buyer terms; ensure compliance with procurement policies for medical items
• Compliance: bidders should be prepared for quantity fluctuations up to 25% and price adjustments within contracted rates
• Eligibility: standard government procurement eligibility implied; manufacturers or authorized distributors likely eligible
• Warranty/penalties: details not provided; bidders should seek clarifications via procurement channel